Interleukin-8. A corneal factor that induces neovascularization.

Area of Science:

• Ophthalmology
• Immunology
• Wound Healing Research

Background:

• Interleukin-8 (IL-8) is a cytokine primarily known for its role in inflammation.
• The role of IL-8 in ocular angiogenesis, particularly in the cornea, is not well understood.
• Understanding cytokine involvement in corneal processes is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the potential of human recombinant IL-8 (rIL-8) to induce corneal neovascularization.
• To determine the dose-dependency and temporal dynamics of rIL-8-induced corneal angiogenesis.
• To explore the relationship between IL-8, inflammation, and corneal wound healing.

Main Methods:

• A rabbit corneal pocket model was employed to assess the angiogenic potential of rIL-8.
• Sequential fluorescein angiograms were analyzed using computer-assisted methods to quantify neovascularization.
• Different doses of rIL-8 were administered, and vascular changes were monitored over 14 days and 6 weeks.

Main Results:

• Physiologic concentrations of rIL-8 (2-40 ng/cornea) induced significant corneal neovascularization within 14 days (P=0.01).
• High-dose rIL-8 (400 ng/cornea) did not result in neovascularization.
• Angiogenesis induced by rIL-8 showed significant regression by 6 weeks (P=0.01), mirroring natural wound healing processes.

Conclusions:

• This study provides the first evidence for an angiogenic role of IL-8 in the cornea.
• IL-8 appears to modulate corneal wound healing, highlighting the interplay between inflammation and angiogenesis.
• Corneal-derived IL-8 may influence neovascularization and potentially confound results in experimental corneal models.